- Pork insulin availability in the UK and Canada assured
- NHS to provide life changing glucose monitors for Type 1 Diabetes patients
- Leading experts slam current diabetes care in UK care homes – a Call to Action needed
- Roche announces urgent recall on certain Accu-Chek Aviva and Performa test strips
- Ramadan 2018 and fasting
- DVLA changes regulations
- Freestyle Libre available on the NHS!
- Medtronic recall specific lots of infusion sets with all models of Medtronic insulin pumps
- All Accu-Chek® Insight insulin pumps – risk of alarm failure
- WHO – long-acting analogues not an essential medicine
- Beef insulin discontinued
- Soft Drinks Warning!
- Driven to Despair
- 2017 – Getting back on track after Christmas
- Childhood Obesity Strategy failing our children
- Diabetes – What schools need to know
- DVLA – Good News!
- The National Diabetes Foot Care Audit (NDFA)
- Diabetes care criticised
- Motorists banned in error after faulty DVLA visual field test
- Too many children and young people with diabetes not getting the care they need
- National NHS Diabetes Prevention Programme
- InDependent Diabetes Trust: Young diabetics ‘get worse care’
- IDDT’s Position Statement – ‘pre-diabetes’
- MBE Is Bolt From The Blue For Charity Chair
- New insulin on the market – Insulin Degludec (Tresiba)
- Diabetes community urges more support for older people
- Warning to people with diabetes about dangerous herbal medicine
- In 1 week, 60 hospital patients with diabetes develop preventable complications – National Audit
- Passport for Diabetes in Care Settings
- Launch of Passport for Diabetes in Care Settings
- Type 2 Diabetes – Management & Medication
- Cost of insulin analogues
- Actos And The Risk Of Bladder Cancer – New Safety Warnings
- Actraphane – are patients really at the centre of care
- Marketing of insulin – a missed opportunity
- IDDT Launch Patient Hospital Passports
- IDDT Launch Public Awareness Campaign
- IDDT’s Position Statement on DTCA
- In Sickness and in Health
- IDDT Triumphs in Australia
Warning to people with diabetes about dangerous herbal medicine
July 3rd 2013
The Medicines and Healthcare products Regulatory Agency (MHRA) today warned people with diabetes not to believe false advertising claims that they can give up their prescribed diabetes medication if they take Vedagrin, an unlicensed herbal medicine.
The advertisement for Vedagrin (also known as Vendate) promotes the unlicensed medicine as an alternative to prescribed diabetes medication with the words "say goodbye to your diabetes medication forever". This breaks advertising regulations for medicines and the MHRA has instructed the company to stop selling the product.
Richard Woodfield, MHRA’s Head of Herbal Policy said: "People with diabetes should ignore these advertising claims and continue to take their prescribed medicine.
"While the patient information leaflet for this unlicensed medicine tells people to seek medical advice before stopping their insulin intake, the advertising claims for this product break advertising regulations for medicines. If these claims are followed they could have dangerous consequences for people with diabetes.
"It’s important that people buy herbal medicines that have either a PL (product licence) or THR (Traditional Herbal Registration) number on the bottom of the packaging. This means the medicines have been assessed against quality standards."